United States of America et al v. Anderson, et al.
Filing
320
MEMORANDUM ORDER: For the reasons stated on the record at the November 19, 2021 pretrial conference, the Court orders as follows: Motions in Limine The United States' second, fourth, and fifth motions in limine (Doc. Nos. 296 , 300 , 302 ) are GRANTED. The Court reserves ruling on the United States first and third motions in limine (Doc. Nos. 294 , 298 ). The parties shall exchange deposition designations by November 22, 2021. The parties shall file brief summaries of their theorie s of the case to be included in the Court's opening jury instructions by noon on December 2, 2021. The parties shall provide their exhibit binders to the Court by noon on December 3, 2021. The deadline to settle and dismiss the case without incurring the cost of summoning the jury is December 3, 2021, at 9:00 a.m. Signed by Magistrate Judge Alistair Newbern on 11/19/2021. (DOCKET TEXT SUMMARY ONLY-ATTORNEYS MUST OPEN THE PDF AND READ THE ORDER.)(vh)
UNITED STATES DISTRICT COURT
FOR THE MIDDLE DISTRICT OF TENNESSEE
NORTHEASTERN DIVISION
UNITED STATES OF AMERICA,
Plaintiff,
Case No. 2:13-cv-00035
v.
Magistrate Judge Alistair E. Newbern
DAVID FLORENCE,
Defendant.
MEMORANDUM ORDER
For the reasons stated on the record at the November 19, 2021 pretrial conference, the
Court orders as follows:
I.
Motions in Limine
The United States’ second, fourth, and fifth motions in limine (Doc. Nos. 296, 300, 302)
are GRANTED. The Court reserves ruling on the United States’ first and third motions in limine
(Doc. Nos. 294, 298).
If Defendant Dr. David Florence’s counsel obtains the longer DocStar video referenced in
his opposition to the United States’ first motion in limine, they shall provide it to the United States
and to the Court within one day of receipt.
II.
Timely Disclosure of Witnesses, Exhibits, and Evidence
Three issues related to the timely disclosure of evidence under the Federal Rules of Civil
Procedure were raised by the parties. First, the United States and counsel for Relator Debra Norris
assert that only two of the twenty-nine witnesses 1 included in Florence’s supplemented witness
list (Doc. No. 317)—Florence and Lorri McGowan—were disclosed by Florence as required by
Federal Rules of Civil Procedure 26 and 37 and that, therefore, the undisclosed witnesses should
be prohibited from testifying at trial. Florence’s counsel did not dispute that the witnesses had not
been disclosed before they were included on his witness list. Second, the United States asserts that
the majority of the exhibits included in Florence’s filed exhibit list (Doc. No. 311) were not
produced at the pretrial conference as directed in the Court’s trial setting order (Doc. No. 285) and
should not be allowed at trial. 2 Florence’s counsel confirmed that, with the exception of one exhibit
that is a premade poster, they did not have exhibits prepared to exchange at the pretrial conference.
Third, Florence’s counsel asserts that the United States has unfairly asserted a new theory of the
case—that the deaths of four of Florence’s patients were related to his over-prescription of
medication—at the eleventh hour. The United States responds that it identified the subject deaths
in medical examiner records, patient files, and the report of its expert witness, Dr. Bistline.
By November 22, 2021, Florence shall file a motion addressing the United States’ assertion
that he did not disclose witnesses and exhibits as required by the Federal Rules of Civil Procedure
and the Court’s prior orders and showing cause why those witnesses and exhibits should be
allowed at trial. Florence shall also make any argument regarding the patient deaths, including the
specific remedy he requests from the Court. If the United States intends to raise any issues arising
out of the pretrial conference by motion, it shall do so by November 22, 2021. The United States
1
Although Florence’s list identifies thirty witnesses, Penny Smithson Shelton is included
twice.
2
The United States does not object to the first, second, seventh, and eighth exhibits on
Florence’s filed exhibit list. (Doc. No. 311.) Nor does the United States object to the introduction
of any publicly available statute or regulation.
2
shall file any response in opposition to Florence’s motion by November 24, 2021. If the United
States files any motion by November 22, 2021, Florence shall file his response by November 24,
2021.
III.
Deposition Designations
The parties shall exchange deposition designations by November 22, 2021. The parties
shall file their deposition designations and any remaining objections as required by Local Rule
39.01(c)(4) by November 29, 2021.
IV.
Case Summaries
The parties shall file brief summaries of their theories of the case to be included in the
Court’s opening jury instructions by noon on December 2, 2021. Any objections to the summaries
shall be filed by noon on December 3, 2021.
V.
Invocation of Federal Rule of Evidence 615
The parties intend to invoke Federal Rule of Evidence 615 to exclude witnesses from the
courtroom so that they will not hear other witnesses’ testimony. The United States asked to except
from this exclusion United States Department of Health and Human Services Special Agent
Richard Haines, who has served as the case agent since the investigation phase of this litigation,
and proposed expert witness Dr. Kathryn Bistline.
Haines’s role is addressed by Federal Rule of Evidence 615(b), which excludes from Rule
615 “an officer or employee of a party that is not a natural person, after being designated as the
party’s representative by its attorney.” Fed. R. Evid. 615(b). “The comments to the rules have
made clear from the beginning that case agents are intended to be included within this exception.”
United States v. Martin, 920 F.2d 393, 397 (6th Cir. 1990). Haines therefore may remain in the
courtroom as the United States’ designated representative.
3
An expert witness may be excepted from Rule 615 if her presence is “show[n] to be
essential to presenting the party’s claim or defense.” Fed. R. Evid. 615(c). To invoke this exception
for its expert witness, the United States must make a “fair showing” that her presence is required
for the management of the case. Morvant v. Constr. Aggregates Corp., 570 F.2d 626, 630 (6th Cir.
1978). The Court will reserve ruling on Dr. Bistline’s exclusion under Rule 615. The United States
may make the appropriate motion when Rule 615 is invoked at the beginning of the trial.
VI.
Exhibit Objections and Binders
The parties shall provide their exhibit binders to the Court by noon on December 3, 2021.
The binders shall include all exhibits to be introduced at trial, premarked by party. The parties
shall also file a joint notice of any objections to the exhibits.
VII.
Further Agreements and Stipulations
Counsel are encouraged to reach further agreement on exhibits to be offered at trial. By
December 2, 2021, counsel shall file a joint notice of their agreements as to the authenticity and
admissibility of exhibits. Counsel shall also notify the Court if they reach further agreement
regarding the motions in limine on which the Court has reserved ruling or any other trial matters.
Counsel are further encouraged to continue their attempts to resolve this matter
independently. The deadline to settle and dismiss the case without incurring the cost of summoning
the jury is December 3, 2021, at 9:00 a.m.
It is so ORDERED.
____________________________________
ALISTAIR E. NEWBERN
United States Magistrate Judge
4
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?